Current Health Briefs: Syphilis Testing, Mpox Emergency, and More

This content provides a concise overview of recent health news, including the FDA's approval of the first at-home syphilis test, the global health emergency status of mpox, the distribution of mpox vaccines to Africa, and the potential spread of the Oropouche virus in the Americas. It also covers the risks posed by contaminated spices in India.

The U.S. FDA has granted marketing authorization for the first at-home syphilis test, developed by NOWDiagnostics, designed to identify syphilis antibodies in about 15 minutes, thereby boosting screening rates for the disease.

The World Health Organization has once again declared mpox, a viral infection that spreads through close contact, a global health emergency. German experts are now advocating for existing mpox vaccine supplies to be sent to Africa, where they are urgently needed.

Bavarian Nordic, a Danish biotech firm, plans to increase production of its mpox vaccine, coordinating with global health organizations to ensure fair access. Meanwhile, the Oropouche virus has emerged in the Americas, causing health concerns.

(With inputs from agencies.)